Clinical Trials Browser

Phase 2 × Hepatitis B × lenvatinib × Clear all

NCT05195294 2025-03-10

Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC

Phase 2 Not yet recruiting

Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular